OncoTartis, Inc. and Children’s Cancer Institute announced the publication of two research manuscripts in a leading onco-hematological journal Leukemia, both devoted to the OncoTartis’ clinical drug candidate OT-82.
International research collaboration reveals promising drug candidate for treatment of blood cancers Buffalo, NY, and Sydney, Australia, January 16, 2020 and /NEWSWIRE/ -- An international research collaboration between the United States and Australia has revealed a promising new drug which could treat high-risk leukemia. Today, OncoTartis, Inc. and Children’s Cancer Institute jointly announced the publication of two research manuscripts in a leading onco-hematological journal Leukemia, both devoted to the OncoTartis’ clinical drug candidate OT-82. A significant proportion of blood cancers in both adults and children remain resistant to current treatments and are often fatal. The results of studies conducted [...]